Effect of phosphodiesterase III Inhibitor (Olprinone) on thoracic duct lymph flow in anesthetized sheep with experimentally induced heart failure by endothelin-1

Lymphology

Volumn 35, Issue 4, 2002, Pages 144-152

  Tomoyasu, M ^b   Onizuka, Masataka ^a   Inagaki, M ^b   Sato, Y ^b   Yamamoto, T ^b   Ishikawa, S ^b   Mitsui, T ^b  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; LOPRINONE; PHOSPHODIESTERASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; ASCENDING AORTA; CARDIOGENIC SHOCK; CENTRAL VENOUS PRESSURE; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEMODYNAMICS; KIDNEY BLOOD FLOW; LUNG PRESSURE; LYMPH FLOW; MALE; NONHUMAN; PRIORITY JOURNAL; RENAL ARTERY; SHEEP; THORACIC DUCT;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANIMALS; CARDIAC OUTPUT; CENTRAL VENOUS PRESSURE; DISEASE MODELS, ANIMAL; ENDOTHELIN-1; ENZYME INHIBITORS; FEMALE; HEART FAILURE, CONGESTIVE; IMIDAZOLES; LUNG; MALE; MODELS, CARDIOVASCULAR; PYRIDONES; RENAL CIRCULATION; SHEEP; SHOCK, CARDIOGENIC; THORACIC DUCT; TIME FACTORS; TREATMENT OUTCOME; VASCULAR RESISTANCE;

EID: 12244260739     PISSN: 00247766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Goto, K, H Hama, K Kasuya: Molecular pharmacology and pathophysiological significance of endothelin. Jap. J. Pharmacol. 72 (1996), 261-290.
2. Miyauchi, T, T Masaki: Pathophysiology of endothelin in the cardiovascular system. Ann. Rev. Physiol. 61 (1999), 391-415.
3. Onizuka, M, T Flatebo, G Nicolaysen: Lymph flow pattern in the intact thoracic duct in sheep. J. Physiol. 503 (1997), 223-234.
4. Iizuka, S, M Onizuka, M Inagaki, et al: Analysis of thoracic duct flow waves using fast fourier transform in sheep. Lymphology 32 (1999), 22-28.
5. Inagaki, M, M Onizuka, S Ishikawa, et al: Thoracic duct lymph flow and its driving pressure in anesthetized sheep. Lymphology 33 (2000), 4-11.
6. Adachi, H, S Kamata, K Kodama, et al: Vasorelaxant effect of phosphodiesterase 3 inhibitor, olprinone, on isolated human radial artery. Eur. J. Pharmacol. 396 (2000), 43-47.
7. Sasayama, S, H Asano, S Ishizaka: Mechanics of contraction and relaxation of the ventricle in experimental heart failure produced by rapid ventricular pacing in the conscious dog. Eur. Heart J. 12(Suppl C) (1991), 35-41.
8. Ogawa, T, H Ohhara, H Tsunoda, et al: Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5- (imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate: first communication: studies on isolated guinea pig cardiac muscles. Arzneimittelforschung 39 (1989), 33-37.
9. Ohhara, H, T Ogawa, M Takeda, et al: Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5- (imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate: second communication: Studies in dogs. Arzneimittelforschung 39 (1989), 38-45.
10. Tanio, H, T Kumada, M Hayashi, et al: Hemodynamic efficacy of E-1020 in comparison with dopamine on acute mitral regurgitation in anesthetized pigs. Jap. Circ. J. 55 (1991), 1068-1076.
11. Inagaki, M, M Onizuka, S Iizuka, et al: Adverse effect of endothelin-1 on thoracic duct and lung lymph flow in anesthetized sheep. FASEB J. 12 (1998), A501(2911).
12. Barratt-Boyes, BG, EH Wood: Cardiac and related measurements and pressure value in the right heart and associated vessels, together with an analysis of hemodynamic response to the inhalation of high oxygen mixtures in healthy subjects. J. Lab. Clin. Med. 51 (1958), 72-90.
13. Yanagisawa, M, H Kurihara, S Kimura, et al: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332 (1988), 411-415.
14. Clozel, JP, M Clozel: Effects of endothelin on the coronary vascular bed in open chest dogs. Circ. Res. 65 (1989), 1193-1200.
15. Cocks, TM, NL Faulkner, K Sudhir, et al: Reactivity of endothelin-1 on human and canine large veins compared with large arteries in vitro. Eur. J. Pharmacol. 96 (1989), 102.
16. Shiba, R, M Yanagisawa, T Miyauchi, et al: Elimination of intravenously injected endothelin-1 from circulation of the rat. J. Cardiol. Pharmacol. 13(Suppl 5) (1989), S98-S101.
17. Morel, DR, JS Lacroix, A Hemsen, et al: Increased plasma and pulmonary lymph levels of endothelin during endotoxin shock. Eur. J. Pharmacol. 167 (1989), 427-428.
18. Igarashi, Y, Y Aizawa, M Tamura, et al: Vasoconstrictor effect of endothelin on the canine coronary artery: is a novel endogenous peptide involved in regulating myocardial blood flow and coronary spasm? Am. Heart J. 118 (1989), 674-678.
19. Kurihara, H, M Yoshizumi, T Sugiyama, et al: The possible role of endothelin-1 in the pathogenesis of coronary vasospasm. J. Cardiovasc. Pharmacol. 13(Suppl 5) (1989), S132-137.
20. Ais, G, C Novo, A Lopez-Farre, et al: Effect of endothelin on systemic and regional hemodynamics in rats. Eur. J. Pharmacol. 170 (1989), 113-116.
21. Murakami, R, K Sano, Y Murakami, et al: Effects of intracoronary infusion of an inotropic agent, E-1020 (loprinone hydrochloride), on cardiac function: Evaluation of left ventricular contractile performance using the end-systolic pressure-volume relationship. Int J Cardiol 51 (1995), 57-63.
22. Unoshima, M, H Iwasaka, S Hattori, et al: Effects of loprinone hydrochloride on hemodynamics and respiratory oxygenation in patients after cardiac surgery. Masui 46 (1997), 1053-1058.
23. He, GW, CQ Yang: Inhibition of vasoconstriction by phosphodiesterase inhibitor milrinone in human conduit arteries used as coronary bypass grafts. J. Cardiovasc. Pharmacol. 28 (1996), 208-214.
24. Weekes, SR, AC Madden, G Bergstrom, et al: Effects of renal arterial endothelin-1 and endogenous endothelins on regional kidney blood flow and renal antihypertensive mechanisms in anesthetized rabbits. Kidney Blood Press Res. 23 (2000), 366-375.
25. Stacy, DL, JW Scott, JP Granger:. Control of renal function during intrarenal infusion of endothelin. Am. J. Physiol. 258 (1990), F1232-1236.
26. Fujishima, K, A Yamamoto, M Hachisu: Effects of amrinone on renal blood flow and cardiac function, in comparison with those of milrinone and olprinone, in anesthetized dog. Nippon Yakurigaku Zasshi 112 (1998), 371-380.
27. Krzeski, R, W Long, H Katayama, et al: Hemodynamic effects of endothelin-1 in the newborn piglet: influence on pulmonary and systemic vascular resistance. J. Cardiovasc. Pharmacol. 17(Suppl 7) (1991), S322-325.
28. Kiely, DG, RI Cargill, AD Struthers, et al: Cardiopulmonary effects of endothelin-1 in man. Cardiovasc. Res. 33 (1997), 378-386.
29. Reeder, LB, MK Fergason: Endoyhelin-1 synthesis and receptor-mediated activity in porcine lymph vessels. J. Surg. Res. 63 (1996), 215-219
30. Sakai, H, F Ikomi, T Ohhashi: Effects of endothelin on spontaneous contraction in lymph vessels. Am. J. Physiol. 277 (1999), 459-466
31. Iribe, G, H Yamada, A Matsunaga, et al: Effects of olprinone on hepatosplanchnic circulation after cardiac surgery. J. Jap. Soc. Intensive Care Med. 5 (1998), 379-384.
32. Iribe, G, H Yamada, A Matsunaga, et al: Effects of the phosphodiesterase inhibitors olprinone, milrinone, and amrinone on hepatosplanchnic oxygen metabolism. Crit. Care Med. 28 (2000), 743-748.